Behaviour

Is taking medication for obesity "cheating"?

Most people who ask are not asking about someone else. They are holding a prescription and asking about themselves. The answer is medical, and so is the cost of believing otherwise.

“Isn’t this cheating?” The question comes up often. And the person asking is usually not a sceptical relative. It is a patient, holding a prescription, asking about themselves.

The answer is no. But the question deserves more than a no, because the feeling underneath it has a clinical name, a known prevalence, and a cost that lands on whoever is carrying it.

Where does the feeling come from?

From an idea most of us absorbed long before any of us needed treatment: that body weight is a running total of self-discipline. Turn that idea inward, onto yourself, and clinicians have a name for it. They call it internalized weight bias.

It has been counted. A study of three samples of American adults found at least 44% endorsed average levels of it. The highest levels showed up in about one in five adults in the two general-population samples. They showed up in 52% of a third sample: 456 adults with obesity already at heightened risk of weight stigma. Canada's obesity guideline names it too: its weight-bias chapter asks clinicians to recognise that internalized weight bias can affect behavioural and health outcomes, and to drop judgmental language in the room. A national guideline treats this as a clinical problem.

Is body weight really a test of willpower?

The genetics say no. A 2022 review of obesity genetics in Nature Reviews Genetics puts it plainly: the genes point to the brain, and to the brain's control of body weight. Those systems don't consult you. They set how hard the day is; they don't decide what you do with it.

That's also why the effort so often doesn't show. We wrote about it in why your body fights weight loss. After weight comes off, hunger rises and energy use falls. The body defends the weight it had. The belief and the biology point in opposite directions, and only one of them has been tested.

The main idea

The medication does not do the work for you. It turns down a signal that was making the same work harder for you than for the person beside you. What you do with a quieter day is still yours.

What does the medication do?

It acts on appetite. In a twelve-week crossover trial in thirty adults, people took in about 24% fewer calories at free-choice meals on semaglutide than on placebo, and reported less hunger, fewer cravings and better control over eating. That trial used the lower dose given for diabetes, so it shows the direction and not the size of the effect. The effect lands on the signal. That is the whole of what a drug can reach.

What it leaves behind is most of the work. The 2025 CMAJ pharmacotherapy update says medication should be used in conjunction with health behaviour change, and its recommendations support long-term use. People taking it describe the same shape in interviews. The authors of one summed it up as a facilitator rather than a replacement.

Honesty about the limits belongs here too. Stopping the medication generally means the weight returns, because the signal it was treating comes back. In the extension of one large trial, participants regained about two thirds of what they had lost within a year of stopping. So treatment gets planned in years. Whether that plan includes medication is still yours to weigh. We cover the muscle side of it in losing weight without losing strength.

What the judgment costs

The judgment is real, and it lands on your health. In a randomised experiment published in the United States in 2026, 402 women, all of them living with overweight or obesity, read about the same woman losing the same amount of weight. When the account said she had used a GLP-1 medication rather than diet and exercise, she was judged more negatively. The belief that she had taken a shortcut is what carried the effect.

A small interview study of nine adults in rural Denmark recorded the words people hear: “cheating,” “an easy way out.” They are the words in this article's title.

Turned inward, that judgment has a measured cost. A systematic review of 74 studies found strong links between internalized weight bias and worse mental health. The evidence linking it to physical health is thinner. One study of adults seeking treatment did find higher internalized bias associated with higher odds of raised triglycerides. The shame doesn't motivate anything. It removes the things that would have helped.

How we approach this at GOALS

GOALS is the obesity and lifestyle medicine program at Guelph Internal Medicine Clinic. The medical care is covered by OHIP: assessment and follow-up, by referral from your family doctor or nurse practitioner. The medication itself is not covered by OHIP, and its cost belongs in the decision early. Whether it has a place in your plan is decided with your physician, alongside nutrition, movement and sleep. You will not be asked to prove that you tried.

You didn't fail your way into needing treatment, and using it doesn't hand the result to somebody else. The work was always going to be yours. When medication is the right fit, it makes some of that ground more level.

Common questions

If I need medication, does that mean I failed at doing it on my own?

No. Body weight is defended by hormones and brain circuits you didn't choose and can't simply decide away. What you eat, how you move and how you sleep still change how they behave. Needing help with a biological process isn't a verdict on your effort. Many people tell us they'd been working at this for years before anyone offered them treatment.

Do I still have to change how I eat and move if I take medication?

Yes. The 2025 Canadian pharmacotherapy guideline says medication should be used in conjunction with health behaviour change, not instead of it. In interview studies, people taking these medications describe them as a facilitator rather than a replacement.

My family says it's the easy way out. What do I say?

That the medication treats an appetite signal, and that everything else still takes work. You're not obliged to justify a medical decision. If it helps: the belief they're repeating is one most of us absorbed long before any of us needed treatment.

Should I be on medication at all?

That's a decision for you and your physician together, weighing your health, your history and what you want. Some people are well served by it and some are not. Ask your family doctor or nurse practitioner about an OHIP-covered obesity medicine consultation.

Marcello Schmidt, MD, MSc, FRCPC, DABOM

Dr. Schmidt is an internal medicine physician and the founder and medical director of Guelph Internal Medicine Clinic, where he leads GOALS, the clinic’s obesity and lifestyle medicine program. He holds Royal College certifications in Internal Medicine and Adult Critical Care and is a Diplomate of the American Board of Obesity Medicine.

Sources & further reading

  1. Kirk SFL, Ramos Salas X, Alberga AS, Russell-Mayhew S. Obesity Canada (2020). Reducing weight bias, stigma and discrimination — Canadian Adult Obesity Clinical Practice Guidelines. Recommendations 2 and 3. obesitycanada.ca
  2. Puhl RM, Himmelstein MS, Quinn DM. Obesity (2018). Internalizing weight stigma: prevalence and sociodemographic considerations in US adults. PubMed 29082666
  3. Pearl RL, Puhl RM. Obesity Reviews (2018). Weight bias internalization and health: a systematic review. Covers 74 studies. PubMed 29788533
  4. Pearl RL, Wadden TA, Hopkins CM, et al. Obesity (2017). Association between weight bias internalization and metabolic syndrome among treatment-seeking individuals with obesity. PubMed 28124502
  5. Loos RJF, Yeo GSH. Nature Reviews Genetics (2022). The genetics of obesity: from discovery to biology. PubMed 34556834
  6. Blundell J, Finlayson G, Axelsen M, et al. Diabetes, Obesity and Metabolism (2017). Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. A 30-person crossover trial using the 1.0 mg diabetes dose, not the higher dose used for weight management. PubMed 28266779
  7. Wilding JPH, Batterham RL, Davies M, et al. Diabetes, Obesity and Metabolism (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. PubMed 35441470
  8. Post SM, Stock ML, Persky S. Stigma and Health (2026). Social perceptions of weight loss with glucagon-like peptide-1 (GLP-1) receptor agonists in Black and White women with obesity. A randomised vignette experiment in 402 US women. PubMed 42181798
  9. Guldhammer A, Drivsholm T, Tomova-Olsen SA, Tranberg Jensen K. Scandinavian Journal of Primary Health Care (2026). A qualitative study exploring experiences about using semaglutide for weight loss in a rural setting in Denmark. Interviews with nine adults. PubMed 41838446
  10. de Vere Hunt I, Ramirez-Posada M, Babu CS, et al. JAMA Network Open (2026). Patient experiences with GLP-1 receptor agonists. Interviews with 30 US adults. PubMed 42247231
  11. Pedersen SD, Manjoo P, Dash S, et al. CMAJ (2025). Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline update. PubMed 40789597

This article is general health information, not personal medical advice. Decisions about starting, continuing or stopping any medication belong with your own prescriber. Ask your family doctor or nurse practitioner about an OHIP-covered obesity medicine consultation.

OHIP-covered Obesity & Lifestyle Medicine

Care starts with a conversation— and a referral.

Start your journey